Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @RnkPetrina
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RnkPetrina
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Petrina proslijedio/la je Tweet
Tomorrow, February 4th, is
#WorldCancerDay
and CADTH is joining the conversation by sharing evidence on #Cancer drugs and health technology. Every action counts. Who are you and what will you do?#IAmAndIWill
pic.twitter.com/MHw81EfOcg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
How proposed changes to the
@PMPRB_CEPMB pricing regime in Canada will impact jobs, investments and most critically, patients in need of life-saving innovative medicines.#cdnpoli#cdnhealth#NewMedsMatter#clincaltrials@innovativemedshttps://lifesciencesontario.ca/news/new-federal-drug-pricing-rules-are-already-delaying-medicine-launches-and-costing-jobs-in-canada-survey-reveals/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
#Blog - Demonstrating bioequivalence (BE) with Certara’s Simcyp MechDermA Model. Read here: https://bit.ly/2S48bwp#dermal#PBPK#genericdrugspic.twitter.com/avo6mWl1ws
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
Featured Report: We completed a review of the clinical effectiveness, cost-effectiveness, patients’ preferences & experiences, as well as the ethical and implementation implications of the use of
#iCBT for the treatment of#PTSD. https://cadth.info/37F3i3j pic.twitter.com/bv7aWHBiCi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Well.. isn't this very interesting..
https://twitter.com/NewsfromScience/status/1222919933652324352 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interesting article/methodology
#ispor#heor#marketaccess@CertaraAccess -> Introducing “Health Years in Total:” A Novel Framework for Valuing Health Outcomes in Cost-Effectiveness Analyses https://www.newswise.com/articles/introducing-health-years-in-total-a-novel-framework-for-valuing-health-outcomes-in-cost-effectiveness-analyses?utm_campaign=Industry+news+&utm_content=twitter&utm_medium=social&utm_source=twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
Click here to read this week’s news and updates on the Guidelines consultation process: http://ow.ly/v2f550y5YCe
#cdnhealth#drugpricesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
Don't miss out on our first webinar of 2020! Tomorrow we will present, "Updates to the Simcyp Simulator’s Oral Absorption ADAM and M-ADAM Models." Register now: https://bit.ly/2ZYtlzl pic.twitter.com/soWP2gsp6Z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
As competition for increasingly constrained healthcare budgets continues to rise, learn about some of the most common tools
#pharma and#medtech field teams are using to secure market access: https://bit.ly/301f7xP#marketaccess#valuecommunicationpic.twitter.com/fm9SNPzqU2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FDA approved Trijardy XR (empagliflozin/linagliptin/metformin hydrochloride, Boehringer Ingelheim/Eli Lilly) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ->https://bit.ly/2GvHWtk
#diabetesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
Artificial intelligence (AI), the term broadly refers to
#computing#technologies that resemble processes associated with#human#intelligence. Explore More @ https://bit.ly/2U0xLoo#Artificialintelligence#Natural_Lag#machinelearning#MarketResearchExplore#Market#Trendspic.twitter.com/kBVslFws5A
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
[2/13 Webinar] We'll discuss how pricing has evolved from the 1990s to today for the rare disease drug market and much more! Register here: https://bit.ly/30UVNmq pic.twitter.com/Xpf0QIrrtA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#CADTH recommended Baqsimi (glucagon, Eli Lilly) for the treatment of severe hypoglycemia reactions which may occur in the management of insulin-treated patients with diabetes mellitus, when impaired consciousness precludes oral carbohydrate ->https://bit.ly/38HZnmrHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interesting study on the need for blinding in clinical trials..https://twitter.com/bmj_latest/status/1221100755454656515 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn from leaders in access and reimbursement at this year's
#CADTHSymp!@CADTH_ACMTS#MarketAccess#Canadianhealthcare#HTAhttps://twitter.com/CADTH_ACMTS/status/1221432761606602753 …
0:06Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Petrina proslijedio/la je Tweet
Free! A compilation of Certara’s biggest challenges and accomplishments in model-informed drug development, health economics/outcomes research and real world evidence, and regulatory science, strategy, and services. To download the blog book, visit https://bit.ly/2RhpSsV pic.twitter.com/aptbxrqz9f
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Petrina proslijedio/la je Tweet
En 2018, les médicaments oncologiques représentaient près du tiers des nouvelles approbations, et un tiers des produits pharmaceutiques émergents. Lisez le nouveau rapport Veille des médicaments mis en marché: http://ow.ly/pqPn50y3su9
#santécan#coûtsmédicamentsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
to go!!!